ZOM stock has been a toxic asset for nearly a year, and Zomedica isn't giving investors much to get enthused about. More
Articles
If Any Real Estate Investment Deserves to Double, It’s Opendoor Technologies
OPEN stock may have been a non-starter in 2021, but a turnaround may be imminent as the company ventures into a pricey real-estate locale. More
Meme Stocks AMC, GME Pop as the DOJ Investigates Short Sellers. What to Know.
Meme stocks like AMC and GME are beating the market today after investors learned the DOJ was investigating short sellers. More
Sharp Correction Is an Opportunity to Buy Marathon Stock
Marathon Digital stock looks attractive after correction. Strong revenue growth visibility for 2022 and 2023 with cash flow upside potential. More
Matterport: The Recent Price Decline Makes MTTR Stock a Buy
MTTR stock has been under significant pressure, especially after management revised down revenue estimates, but could become a takeover target in 2022. More
Cenntro Electric Has a Fascinating Story but Few Results
CENN stock has a peculiar story but is lacking as a company. It should be avoided now amid the lack of key financial results. More
Is SHOP a Buy Right Now? 3 Analysts Weigh In on Shopify Price Predictions.
Shopify price predictions are everywhere today after SHOP stock takes a steep tumble following a lukewarm earnings call. More
